Iva Johansson

3.5k total citations
26 papers, 812 citations indexed

About

Iva Johansson is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Iva Johansson has authored 26 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 3 papers in Neurology. Recurrent topics in Iva Johansson's work include Cutaneous Melanoma Detection and Management (11 papers), Melanoma and MAPK Pathways (7 papers) and Neuroblastoma Research and Treatments (3 papers). Iva Johansson is often cited by papers focused on Cutaneous Melanoma Detection and Management (11 papers), Melanoma and MAPK Pathways (7 papers) and Neuroblastoma Research and Treatments (3 papers). Iva Johansson collaborates with scholars based in Sweden, United States and Australia. Iva Johansson's co-authors include Sven Påhlman, Martin Schalling, Erik Lindgren, Roger Olofsson Bagge, Carolina Gestblom, Cecilia Lässer, Jan Lötvall, Johanna L. Höög, Henna Söderholm and Su Chul Jang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Iva Johansson

24 papers receiving 803 citations

Peers

Countries citing papers authored by Iva Johansson

Since Specialization

Citations

This map shows the geographic impact of Iva Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iva Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iva Johansson more than expected).

Fields of papers citing papers by Iva Johansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iva Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iva Johansson. The network helps show where Iva Johansson may publish in the future.

Co-authorship network of co-authors of Iva Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Iva Johansson. A scholar is included among the top collaborators of Iva Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iva Johansson. Iva Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CP-GEP identifies high-risk T1a melanoma patients beyond established adverse features 2025 ·Journal of the American Academy of Dermatology ·Wesley Y. Yu, (unknown), (unknown), Lisbet Rosenkrantz Hölmich, Iva Johansson, Roger Olofsson Bagge, (unknown), Suraj Venna, Julie Jackson, Teresa Amaral, Alexander C. J. van Akkooi, Michael S. Kolodney, Grant A. McArthur, Alexander Meves	0
2	Unilateral amelanotic conjunctival malignant melanoma: a case report 2024 ·Journal of Medical Case Reports ·Marcelo Ayala, (unknown), Iva Johansson	1
3	Clinical validation of a prognostic 7-marker IHC assay (7-IHC) in 382 patients (pts) with stage IB/IIA cutaneous melanoma (CM; MELARISK-001). 2024 ·Journal of Clinical Oncology ·Teresa Amaral, Stephan Forchhammer, (unknown), Iva Johansson, Eduardo Nagore, (unknown), (unknown), Barbara L. van Leeuwen, (unknown), José Bañuls, (unknown), (unknown), Ann‐Sophie Bohne, Jyri Teras, Merrick I. Ross, Alexander Christopher Jonathan Van Akkooi, Jeffrey S. Weber, Dirk Schadendorf, Roger Olofsson Bagge, Axel Hauschild	1
4	Development of an optimized MRI protocol for a rapid preoperative identification of sentinel lymph nodes using superparamagnetic iron oxide – The Gothenburg fast acquisition sentinel lymph node tracking magnetic resonance imaging protocol (GO-FAST-MRI) 2024 ·European Journal of Surgical Oncology ·(unknown), (unknown), (unknown), (unknown), Iva Johansson, Fredrik Wärnberg, Henrik Leonhardt, Roger Olofsson Bagge	0
5	Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk for disease relapse 2023 ·European Journal of Surgical Oncology ·Evalyn E.A.P. Mulder, Iva Johansson, Dirk J. Grünhagen, Dennie Tempel, (unknown), Jvalini Dwarkasing, D. Verver, Antien L. Mooyaart, (unknown), Tamar Nijsten, Cornelis Verhoef, Jan Mattsson, Lars Ny, Loes M. Hollestein, Roger Olofsson Bagge	1
6	Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy 2023 ·Cancer Research Communications ·Vasu R. Sah, Henrik Jespersen, Joakim Karlsson, Lisa M. Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadóttir, Max Levin, Gustav Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas A. Nilsson, Lars Ny	6
7	DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype 2022 ·JCI Insight ·(unknown), Bengt Phung, Shamik Mitra, Martin Lauss, Jiyeon Choi, Tongwu Zhang, Ching-Ni Jenny Njauw, Eugenia Cordero, Katja Harbst, Frida Rosengren, Rita Cabrita, Iva Johansson, Karolin Isaksson, Christian Ingvar, Ana Carneiro, Kevin M. Brown, Hensin Tsao, My Andersson, Kristian Pietras, Göran Jönsson	9
8	Sentinel lymph node localization and staging with a low-dose of superparamagnetic iron oxide (SPIO) enhanced MRI and magnetometer in patients with cutaneous melanoma of the extremity - The MAGMEN feasibility study 2022 ·European Journal of Surgical Oncology ·(unknown), (unknown), (unknown), (unknown), Iva Johansson, Henrik Leonhardt, Fredrik Wärnberg, Roger Olofsson Bagge	10
9	Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I–II Melanoma Patients at Risk of Disease Relapse 2022 ·Cancers ·Evalyn E.A.P. Mulder, Iva Johansson, Dirk J. Grünhagen, Dennie Tempel, (unknown), Jvalini Dwarkasing, D. Verver, Antien L. Mooyaart, Astrid A.M. van der Veldt, Marlies Wakkee, Tamar Nijsten, Cornelis Verhoef, Jan Mattsson, Lars Ny, Loes M. Hollestein, Roger Olofsson Bagge	20
10	Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary 2021 ·European Journal of Surgical Oncology ·Iva Johansson, Dennie Tempel, Jvalini Dwarkasing, (unknown), Jan Mattsson, Lars Ny, Roger Olofsson Bagge	27
11	Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes 2021 ·European Urology ·Gottfrid Sjödahl, (unknown), (unknown), Carina Bernardo, Gunilla Chebil, Pontus Eriksson, Iva Johansson, Petter Kollberg, Claes Lindh, Kristina Lövgren, Nour‐Al‐Dain Marzouka, Hans Olsson, Mattias Höglund, Anders Ullén, Fredrik Liedberg	89
12	PD‐1 inhibitor therapy of basal cell carcinoma with pulmonary metastasis 2021 ·Journal of the European Academy of Dermatology and Venereology ·Iva Johansson, Max Levin, Levent M. Akyürek, Roger Olofsson Bagge, Lars Ny	3
13	Tumor genetic heterogeneity analysis of chronic sun‐damaged melanoma 2019 ·Pigment Cell & Melanoma Research ·(unknown), Katja Harbst, Iva Johansson, (unknown), Martin Lauss, Shamik Mitra, Frida Rosengren, Jari Häkkinen, Johan Vallon‐Christersson, Håkan Olsson, (unknown), Karolin Isaksson, Christian Ingvar, K. Nielsen, Göran Jönsson	27
14	Naevoid Malignant Melanoma: A Diagnosis of a Naevus That You Later Regret 2017 ·Acta Dermato Venereologica ·G. Theodosiou, Iva Johansson, Nils Hamnerius, Åke Svensson	6
15	Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma 2012 ·Clinical Cancer Research ·Katja Harbst, Johan Staaf, Martin Lauss, Anna Karlsson, Anna Måsbäck, Iva Johansson, Pär‐Ola Bendahl, Johan Vallon‐Christersson, Therese Törngren, Henrik Ekedahl, Jürgen Geisler, Mattias Höglund, Markus Ringnér, Lotta Lundgren, Karin Jirström, Håkan Olsson, Christian Ingvar, Åke Borg, Hensin Tsao, Göran Jönsson	72
16	Extended Phylogeny of Equine Arteritis Virus: Division into New Subgroups 2006 ·Journal of Veterinary Medicine Series B ·Christian Mittelholzer, Tomasz Stadejek, Iva Johansson, Claudia Baule, (unknown), D. Hannant, David J. Paton, Gian Luca Autorino, Norbert Nowotny, Sándór Belák	15
17	Differentiation and survival influences of growth factors in human neuroblastoma 1995 ·European Journal of Cancer ·Sven Påhlman, (unknown), Eewa Nånberg, F Hedborg, (unknown), Carolina Gestblom, Iva Johansson, Ulf Larsson, Erik Lavenius, (unknown), Henna Söderholm	137
18	Protein synthesis and mRNA in isolated growth cones from differentiating SH‐SY5Y neuroblastoma cells 1994 ·Journal of Neuroscience Research ·(unknown), Vendela Parrow, Carolina Gestblom, Iva Johansson, Sven Påhlman	4
19	Activation of the human NPY gene during neuroblastoma cell differentiation: induced transcriptional activities of AP-1 and AP-2. 1994 ·PubMed ·Göran Andersson, Sven Påhlman, (unknown), Iva Johansson, Ulf Hammerling	38
20	Platelet-derived growth factor potentiates phorbol ester-induced neuronal differentiation of human neuroblastoma cells. 1992 ·PubMed ·Sven Påhlman, Iva Johansson, Bengt Westermark, Monica Nistér	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact